Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. Journal Of Clinical Oncology 2020, 38: 1346-1366. PMID: 31928404, DOI: 10.1200/jco.19.02309.Peer-Reviewed Original ResearchConceptsProgesterone receptor testingBreast cancerEndocrine therapyReceptor testingExpert panelClinical practice guideline recommendationsMultidisciplinary international expert panelClinical Oncology/CollegeEndocrine therapy benefitPractice guideline recommendationsER-positive cancersBreast cancer guidelinesInvasive breast cancerFuture breast cancerBreast cancer samplesInternational expert panelReporting of casesPgR testingTumor cell nucleiCancer guidelinesGuideline recommendationsGuideline updateDuctal carcinomaER testingLow positives